Faculty of Pharmaceutical Sciences

Activities

Activities per year 1990 2011 2012 2013 2014 2015 2016 2017 2018 2025

• 2140 Oral presentation
• 78 social activities
• 52 Academic activities
• 18 Invited talk
• 12 More
  • 5 Other reseach activity
  • 5 Other educational activity
  • 1 Participating in a conference, workshop
  • 1 Editorial work

Activities per year

Search results

• Aβ25-35脳室内投与によって誘導される学習記憶障害に対するRosmarinic acidの改善作用

  Nitta, A. (Speaker)

  2006/03/08 → 2006/03/10

  Activity: Talk or presentation › Oral presentation

• Aβ (25-35) 脳室内投与による記憶障害マウスにおけるリン酸化CRMP2の役割

  Nitta, A. (Speaker)

  2008/07/09 → 2008/07/11

  Activity: Talk or presentation › Oral presentation

• Azides and Alkenes/Alkynes: New Methods and Their Applications on Natural Product chemistry

  Tanimoto, H. (Speaker)

  2013/06/18

  Activity: Talk or presentation › Oral presentation

• Augmented mechanical response of substantia gelatinosa neurons in a rat model of fibromyalgia.

  Uta, D. (Speaker)

  2017/07

  Activity: Talk or presentation › Oral presentation

• Augmented mechanical response of spinal dorsal horn neurons in a rat model of fibromyalgia.

  Uta, D. (Speaker)

  2022/11/30 → 2022/12/03

  Activity: Talk or presentation › Oral presentation

• Aucubin contributes to the inhibitory action of goshajinkigan on mechanical allodynia induced by paclitaxel in mice.

  Uta, D. (Speaker)

  2016/09

  Activity: Talk or presentation › Oral presentation

• Attenuation pharmacological effects of methamphetamine by Piccolo knockdown in the nucleus accombens in mice

  Nitta, A. (Speaker)

  2018/06/16 → 2018/06/19

  Activity: Talk or presentation › Oral presentation

• Attenuation of the formation of CPP by methamphetamine in Shati/Nat8l overexpressed mice in the prefrontal cortex

  Nitta, A. (Speaker)

  2018/06/16 → 2018/06/19

  Activity: Talk or presentation › Oral presentation

• Attenuation of methamphetamine-induced CPP by Shati/Nat8l overexpression in medial prefrontal cortex of mice.

  Nitta, A. (Speaker)

  2018/09/10 → 2018/09/11

  Activity: Talk or presentation › Oral presentation

• Attenuation of methamphetamine-induced CPP by Shati/Nat8l overexpression in medial prefrontal cortex of mice

  Nitta, A. (Speaker)

  2018/09/10 → 2018/09/11

  Activity: Talk or presentation › Oral presentation

• A tightly hybridizable, DNA-like architecture as a sequence-selective assembly in water

  Chiba, J. (Speaker)

  2015/11/22 → 2015/11/23

  Activity: Talk or presentation › Oral presentation

• A study of pharmacist-patient communication: Development of a communication learning program for pharmacists.

  Nitta, A. (Speaker)

  2013/08/31 → 2013/09/05

  Activity: Talk or presentation › Oral presentation

• A strategy for the synthesis of all 16 stereoisomers of homonojirimycin (HNJ).

  Kato, A. (Speaker)

  2010/08/01 → 2010/08/06

  Activity: Talk or presentation › Oral presentation

• Aquilaria microcarpa培養細胞におけるd-guaiene synthase遺伝子転写活性の誘導

  Lee, J. (Speaker)

  2015/03/25 → 2015/03/28

  Activity: Talk or presentation › Oral presentation

• Aquilaria microcarpa培養細胞におけるdelta-guaiene synthase活性の誘導

  Lee, J. (Speaker)

  2015/09/11 → 2015/09/12

  Activity: Talk or presentation › Oral presentation

• A pruritogen 5-HT-induced itching on synaptic transmission in spinal superficial dorsal horn neurons -In vivo patch-clamp recording analyse-.

  Uta, D. (Speaker)

  2018/07

  Activity: Talk or presentation › Oral presentation

• Application of chronotherapy to decrease side effect

  To, H. (Speaker)

  2012/03

  Activity: Talk or presentation › Oral presentation

• A pain-enhancing mechanism through TRPV1-ANO1 interaction, and its inhibition effect by drag.

  Uta, D. (Speaker)

  2014/11/15 → 2014/11/19

  Activity: Talk or presentation › Oral presentation

• A pain-enhancing mechanism involving the interaction between TRPV1 and anoctamin 1.

  Uta, D. (Speaker)

  2014/06/20 → 2014/06/21

  Activity: Talk or presentation › Oral presentation

• Drug discovery from Natural medicine utilizing the food and drug classification

  Tohda, C. (Invited speaker), Yang, X. (Speaker) & Inada, Y. (Speaker)

  2022/11/30 → 2022/12/03

  Activity: Talk or presentation › Invited talk

• Drug discovery from Natural medicine utilizing the food and drug classification

  Tohda, C. (Invited speaker), Yang, X. (Speaker) & Inada, Y. (Speaker)

  2022/11/30 → 2022/12/03

  Activity: Talk or presentation › Invited talk

• Anxiety and schizophrenia-like behaviors induced by TMEM168 overexpression in the nucleus accumbens of mice.

  Nitta, A. (Speaker)

  2014/03/19 → 2014/03/21

  Activity: Talk or presentation › Oral presentation

• Antipruritic effect of alpha2delta ligands in a mouse model of atopic dermatitis.

  Uta, D. (Speaker)

  2021/12/10 → 2021/12/11

  Activity: Talk or presentation › Oral presentation

• Anti-melanoma effect of CDK inhibitor and its combination strategy with BRAF inhibition

  Yokoyama, S. (Speaker)

  2018/09

  Activity: Talk or presentation › Oral presentation

• Anti-influenza A virus and anti-herpes simplex virus activities of Bifidobacterium longnum in mice with normal and compromised immunity.

  Lee, J. (Speaker)

  2016/11/02 → 2016/11/04

  Activity: Talk or presentation › Oral presentation

• Anti-inflammatory effect of Morus alba L. bark to suppresses Toll-like receptor activation in RAW264.7 macrophages

  Yokoyama, S. (Speaker)

  2017/10

  Activity: Talk or presentation › Oral presentation

• Antagonism of mineralocorticoid receptor ameliorates systemic insulin resistance and steatohepatitis in a novel mouse model of non-alcoholic steatohepatitis (NASH) utilizing liver-specific SREBP1c transgenic mice.

  Wada, T. (Speaker)

  2011/01/12 → 2011/01/17

  Activity: Talk or presentation › Oral presentation

• Antagonism of mineralocorticoid receptor ameliorates systemic insulin resistance and steatohepatitis in a novel mouse model of non-alcoholic steatohepatitis (NASH) utilizing liver-specific SREBP1c transgenic mice.

  Sasaoka, T. (Speaker)

  2011/01/12 → 2011/01/17

  Activity: Talk or presentation › Oral presentation

• Antagonism of mineralocorticoid receptor ameliorates systemic insulin resistance and steatohepatitis in a novel mouse model of non-alcoholic steatohepatitis (NASH) utilizing liver-specific SREBP1c transgenic mice.

  Tsuneki, H. (Speaker)

  2011/01/12 → 2011/01/17

  Activity: Talk or presentation › Oral presentation

• A novel toxicoproteomic method based on fluorogenic-derivatization-liquid chromatography-tandem mass spectrometry and its application study

  To, H. (Speaker)

  2011/11

  Activity: Talk or presentation › Oral presentation

• A novel molecule ''shati'' inhibits methamphetamine-induced hyperlocomotion, sensitization, and conditioned place preference via tumor necrosis factor-α.

  Nitta, A. (Speaker)

  2008/11/15 → 2008/11/19

  Activity: Talk or presentation › Oral presentation

• A novel molecule 'shati' increases dopamine uptake via the induction of TNF-α in PC12 cells.

  Nitta, A. (Speaker)

  2011/05/15 → 2011/05/18

  Activity: Talk or presentation › Oral presentation

• A novel coupling reaction between thioamides and sulfonyl azides

  Chiba, J. (Speaker)

  2016/09/12 → 2016/09/13

  Activity: Talk or presentation › Oral presentation

• A novel bipolar syndrome animal model via reduction of Teneurin-4, the protein encoded by ODZ4, in the prefrontal cortex of mice

  Asano, T. (Speaker)

  2021/03/08 → 2021/03/10

  Activity: Talk or presentation › Oral presentation

• A novel a-glucan from an edible mushroom, Grifola frondosa (Maitake), exerts the therapeutic effects on influenza A virus infection.

  Lee, J. (Speaker)

  2017/10/15 → 2017/10/20

  Activity: Talk or presentation › Oral presentation

• A nitro sugar based route to branched-chain polyhydroxylated octahydro-1H-indole-4,5,6-triols, as new potential glycosides inhibitors.

  Kato, A. (Speaker)

  2014/05/28 → 2014/05/30

  Activity: Talk or presentation › Oral presentation

• An inducer for GDNF and TNF-α protects methamphetamine-induced rewarding effects and sensitization.

  Nitta, A. (Speaker)

  2006/10/14 → 2006/10/18

  Activity: Talk or presentation › Oral presentation

• An inducer for GDNF and TNF-α protects methamphetamine-induced reward and sensitization. (Workshop)

  Nitta, A. (Speaker)

  2006/01/18

  Activity: Talk or presentation › Oral presentation

• AngiotensinⅡ曝露した培養血管内皮細胞でのインスリン抵抗性に対するcoenzyme Q10の効果．

  Tsuneki, H. (Speaker)

  2013/10/06

  Activity: Talk or presentation › Oral presentation

• AngiotensinⅡ曝露した培養血管内皮細胞でのインスリン抵抗性に対するcoenzyme Q10の効果．

  Sasaoka, T. (Speaker)

  2013/10/06

  Activity: Talk or presentation › Oral presentation

• AngiotensinⅡ曝露した培養血管内皮細胞でのインスリン抵抗性に対するcoenzyme Q10の効果．

  Wada, T. (Speaker)

  2013/10/06

  Activity: Talk or presentation › Oral presentation

• A new target in the treatment for neuropathic pain induced by nerve injury.

  Uta, D. (Speaker)

  2013/08/04 → 2013/08/07

  Activity: Talk or presentation › Oral presentation

• A new regulator of OX40 co-signaling controls autoimmune neuroinflammation mediated by CD4+ T cells.

  So, T. (Speaker)

  2017/12/12 → 2017/12/14

  Activity: Talk or presentation › Oral presentation

• A neuroprotective dipeptide, Leu-Ile, prevents the impairment of memory induced by amyloid beta in mice via restraining the hyperphosphorylation of ERK in the hippocampus.

  Nitta, A. (Speaker)

  2009/10/17 → 2009/10/21

  Activity: Talk or presentation › Oral presentation

• A natural scavenger of peroxynitrites, rosmarinic acid, protects against impairment of memory induced by Abeta (25-35).

  Nitta, A. (Speaker)

  2007/09/10 → 2007/09/12

  Activity: Talk or presentation › Oral presentation

• A natural scavenger of peroxynitrite, rosmarinic acid, protects against impairment of memory induced by Abeta(25-35).

  Nitta, A. (Speaker)

  2007/11/03 → 2007/11/07

  Activity: Talk or presentation › Oral presentation

• Anatomical substrates for the discriminative stimulus effects of methamphetamine in rats.

  Nitta, A. (Speaker)

  2002/11/02 → 2002/11/07

  Activity: Talk or presentation › Oral presentation

• Anatomical substrates for the discriminative stimulation of methamphetamine in rats.

  Nitta, A. (Speaker)

  2003/07/31 → 2003/08/01

  Activity: Talk or presentation › Oral presentation

• An analogue of dipeptide-like structure of FK506 increases GDNF expression through CREB activated by Hsp90/Akt signaling pathway. (Workshop)

  Nitta, A. (Speaker)

  2006/01/18

  Activity: Talk or presentation › Oral presentation

• Analysis of pharmacist-patient communication using the roter method of interaction process annalysis system.

  Nitta, A. (Speaker)

  2015/09/29 → 2015/10/03

  Activity: Talk or presentation › Oral presentation